BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 908445)

  • 1. Vaginal absorption of estrone and 17beta-estradiol.
    Schiff I; Tulchinsky D; Ryan KJ
    Fertil Steril; 1977 Oct; 28(10):1063-6. PubMed ID: 908445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sublingual absorption of micronized 17beta-estradiol.
    Burnier AM; Martin PL; Yen SS; Brooks P
    Am J Obstet Gynecol; 1981 May; 140(2):146-50. PubMed ID: 6786097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
    Gupta P; Ozel B; Stanczyk FZ; Felix JC; Mishell DR
    Menopause; 2008; 15(1):94-7. PubMed ID: 17882008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma estriol and its conjugates following oral and vaginal administration of estriol to postmenopausal women: correlations with gonadotropin levels.
    Schiff I; Tulchinsky D; Ryan KJ; Kadner S; Levitz M
    Am J Obstet Gynecol; 1980 Dec; 138(8):1137-41. PubMed ID: 6778214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic studies on low dose estradiol 17 beta administered orally to postmenopausal women.
    Sipinen S; Lähteenmäki P; Luukkainen T
    Acta Obstet Gynecol Scand; 1980; 59(2):149-53. PubMed ID: 6773291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine and clinical effects of estradiol and testosterone pellets used in long-term replacement therapy.
    Kapetanakis E; Dmowski WP; Auletta F; Scommegna A
    Int J Gynaecol Obstet; 1982 Oct; 20(5):387-99. PubMed ID: 6128271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estradiol, estrone, and gonadotropin levels after use of vaginal estradiol.
    Martin PL; Greaney MO; Burnier AM; Brooks PM; Yen SS; Quigley ME
    Obstet Gynecol; 1984 Apr; 63(4):441-4. PubMed ID: 6422370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorption of estrogens from vaginal creams.
    Rigg LA; Hermann H; Yen SS
    N Engl J Med; 1978 Jan; 298(4):195-7. PubMed ID: 201842
    [No Abstract]   [Full Text] [Related]  

  • 9. Absorption of percutaneous oestradiol in postmenopausal women.
    Sitruk-Ware R; de Lignieres B; Basdevant A; Mauvais-Jarvis P
    Maturitas; 1980 Oct; 2(3):207-11. PubMed ID: 6777634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-menopausal concentrations of plasma oestradiol, oestrone, FSH and LH and of total urinary oestradiol and oestrone after a single sublingual dose of oestradiol-17 beta.
    Fiet J; Hermano M; Witte J; Villette JM; Haimart M; Gourmel B; Tabuteau F; Rouffy J; Dreux C
    Acta Endocrinol (Copenh); 1982 Sep; 101(1):93-7. PubMed ID: 6812348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine studies in postmenopausal women during oral replacement therapy with unconjugated oestrogens.
    Vasquez JM; Samaras CA; Nezhat C
    Reproduccion; 1982; 6(2):49-59. PubMed ID: 6216132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological effects of various doses of vaginally administered conjugated equine estrogens in postmenopausal women.
    Mandel FP; Geola FL; Meldrum DR; Lu JH; Eggena P; Sambhi MP; Hershman JM; Judd HL
    J Clin Endocrinol Metab; 1983 Jul; 57(1):133-9. PubMed ID: 6304131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological effects of estradiol-17 beta in postmenopausal women: oral versus percutaneous administration.
    De Lignieres B; Basdevant A; Thomas G; Thalabard JC; Mercier-Bodard C; Conard J; Guyene TT; Mairon N; Corvol P; Guy-Grand B
    J Clin Endocrinol Metab; 1986 Mar; 62(3):536-41. PubMed ID: 3080464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of conjugated oestrogens on circulating oestradiol, oestrone, LH, FSH and prolactin levels in postmenopausal women.
    Luisi M; Franchi F; Argenio GF; Barletta D; Romano MR; Bernini GP; Gasperi M; Sgrilli R
    Int J Tissue React; 1981 Jun; 3(2):77-81. PubMed ID: 6799393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of estradiol vaginal cream in postmenopausal women.
    Dickerson J; Bressler R; Christian CD; Hermann HW
    Clin Pharmacol Ther; 1979 Oct; 26(4):502-7. PubMed ID: 226306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic hyperestrogenemia: lack of positive feedback action on gonadotropin-releasing hormone-induced luteinizing hormone release and dual site of negative feedback action.
    Richardson DW; Gordon K; Billiar RB; Little AB
    Endocrinology; 1992 Mar; 130(3):1090-6. PubMed ID: 1537275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma endothelin and LH-RH, LH, FSH, prolactin, progesterone, 17alpha-hydroxyprogesterone, estrone, 17beta-estradiol, delta4-androstenedione, testosterone, active renin, angiotensin-II and ANP levels in blood and LH, estrone and 17beta-estradiol and pregnanediol levels in urine of normal cycling women.
    Usuki S; Kondoh K; Kubo T
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S421-7. PubMed ID: 11078439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transformation of estrone, estradiol, and estrone sulfate in uterine and vaginal isolated cells of fetal guinea pig. Effect of various antiestrogens in the conversion of estrone sulfate to estradiol.
    Urabe M; Chetrite G; Pasqualini JR
    Steroids; 1993 May; 58(5):209-14. PubMed ID: 8356572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of luteal estradiol on the secretory transformation of human endometrium and plasma gonadotropins.
    de Ziegler D; Bergeron C; Cornel C; Medalie DA; Massai MR; Milgrom E; Frydman R; Bouchard P
    J Clin Endocrinol Metab; 1992 Feb; 74(2):322-31. PubMed ID: 1730810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of thyrotropin-releasing hormone on the postmenopausal female.
    Lee SG; Lundy LE; Kashef M; Dorn J
    Obstet Gynecol; 1975 Jan; 45(1):25-6. PubMed ID: 803307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.